• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蜱传黄病毒包膜蛋白结构域III的生物物理特性及载体特异性拮抗活性

Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.

作者信息

Bhardwaj S, Holbrook M, Shope R E, Barrett A D, Watowich S J

机构信息

Department of Human Biological Chemistry & Genetics and Sealy Center for Structural Biology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

出版信息

J Virol. 2001 Apr;75(8):4002-7. doi: 10.1128/JVI.75.8.4002-4007.2001.

DOI:10.1128/JVI.75.8.4002-4007.2001
PMID:11264392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC114894/
Abstract

The molecular determinants responsible for flavivirus host cell binding and tissue tropism are largely unknown, although domain III of the envelope protein has been implicated in these functions. We examined the solution properties and antagonist activity of Langat virus domain III. Our results suggest that domain III adopts a stably folded structure that can mediate binding of tick-borne flaviviruses but not mosquito-borne flaviviruses to their target cells. Three clusters of phylogenetically conserved residues are identified that may be responsible for the vector-specific antagonist activity of domain III.

摘要

尽管包膜蛋白的结构域III被认为与这些功能有关,但负责黄病毒宿主细胞结合和组织嗜性的分子决定因素在很大程度上尚不清楚。我们研究了兰加特病毒结构域III的溶液特性和拮抗活性。我们的结果表明,结构域III采用稳定折叠的结构,可介导蜱传黄病毒而非蚊传黄病毒与其靶细胞的结合。鉴定出三个系统发育保守残基簇,它们可能负责结构域III的载体特异性拮抗活性。

相似文献

1
Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.蜱传黄病毒包膜蛋白结构域III的生物物理特性及载体特异性拮抗活性
J Virol. 2001 Apr;75(8):4002-7. doi: 10.1128/JVI.75.8.4002-4007.2001.
2
Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses.蚊媒和蜱媒黄病毒包膜蛋白结构域III的溶液结构与结构动力学
Biochemistry. 2004 Jul 20;43(28):9168-76. doi: 10.1021/bi049324g.
3
Langat virus M protein is structurally homologous to prM.兰加特病毒M蛋白在结构上与prM同源。
J Virol. 2001 Apr;75(8):3999-4001. doi: 10.1128/JVI.75.8.3999-4001.2001.
4
Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.鄂木斯克出血热病毒包膜蛋白结构域III的结构
Virology. 2006 Jul 20;351(1):188-95. doi: 10.1016/j.virol.2006.03.030. Epub 2006 May 2.
5
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses.波瓦桑病毒的完整基因组序列:蜱传与蚊传黄病毒遗传元件的评估
Virology. 1993 May;194(1):173-84. doi: 10.1006/viro.1993.1247.
6
Identification of oligopeptides mimicking the receptor-binding domain of Hantaan virus envelope glycoprotein from a phage-displayed peptide library.从噬菌体展示肽库中鉴定模拟汉坦病毒包膜糖蛋白受体结合域的寡肽。
Can J Microbiol. 2009 Jun;55(6):664-71. doi: 10.1139/w09-012.
7
Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.黄病毒包膜蛋白的结构域III肽是用于血清学诊断的有用抗原和免疫接种的靶点。
Biologicals. 2010 Nov;38(6):613-8. doi: 10.1016/j.biologicals.2010.07.004.
8
Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.登革病毒主要包膜蛋白在传代过程中的变化及其在该蛋白三维结构上的定位。
Virology. 1997 Jun 9;232(2):281-90. doi: 10.1006/viro.1997.8570.
9
[Protein E 98-113 sequence is a fusion site of tick-borne encephalitis virus with cellular membrane].[蛋白质E 98 - 113序列是蜱传脑炎病毒与细胞膜的融合位点]
Bioorg Khim. 1998 Sep;24(9):676-81.
10
Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.基于重组E蛋白结构域III的酶联免疫吸附测定法在区分蜱传脑炎血清复合群黄病毒与蚊传黄病毒中的应用。
J Clin Microbiol. 2004 Sep;42(9):4101-10. doi: 10.1128/JCM.42.9.4101-4110.2004.

引用本文的文献

1
The recombinant truncated envelope protein of West Nile virus adjuvanted with Alum/CpG induces potent humoral and T cell immunity in mice.用明矾/胞嘧啶-磷酸-鸟嘌呤(CpG)佐剂的西尼罗河病毒重组截短包膜蛋白可在小鼠中诱导强效的体液免疫和T细胞免疫。
Biosaf Health. 2023 Jun 27;5(5):300-307. doi: 10.1016/j.bsheal.2023.06.003. eCollection 2023 Oct.
2
Identifying citrus limonoids as a potential fusion inhibitor of DENV-2 virus through its in silico study and FTIR analysis.通过计算机模拟研究和傅里叶变换红外光谱分析确定柑橘类柠檬苦素作为登革热病毒2型的潜在融合抑制剂。
In Silico Pharmacol. 2024 Apr 25;12(1):35. doi: 10.1007/s40203-024-00207-2. eCollection 2024.
3
A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology.利用病毒样颗粒(VLP)平台技术对寨卡病毒感染的天然抗体反应所针对的线性表位进行作图的方法。
Virology. 2023 Feb;579:101-110. doi: 10.1016/j.virol.2023.01.001. Epub 2023 Jan 4.
4
How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika.抗体如何识别病原体病毒:HIV-1、SARS-CoV-2 和寨卡病毒抗体中和作用的结构相关性。
Viruses. 2021 Oct 19;13(10):2106. doi: 10.3390/v13102106.
5
Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.人类浆细胞样树突状细胞处于I型干扰素调节的B细胞分化与对蜱传脑炎病毒的抗病毒反应的交叉点。
PLoS Pathog. 2021 Apr 15;17(4):e1009505. doi: 10.1371/journal.ppat.1009505. eCollection 2021 Apr.
6
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.寨卡病毒包膜结构域III在DNA、蛋白质和ChAdOx1腺病毒载体疫苗中的免疫原性和效力
Vaccines (Basel). 2020 Jun 16;8(2):307. doi: 10.3390/vaccines8020307.
7
Early Events in Japanese Encephalitis Virus Infection: Viral Entry.日本脑炎病毒感染的早期事件:病毒进入
Pathogens. 2018 Aug 13;7(3):68. doi: 10.3390/pathogens7030068.
8
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.人类对黄病毒抗体反应的光明面和黑暗面:对疫苗设计的启示。
EMBO Rep. 2018 Feb;19(2):206-224. doi: 10.15252/embr.201745302. Epub 2017 Dec 27.
9
A synthetic peptide derived from domain III envelope glycoprotein of Dengue virus induces neutralizing antibody.一种源自登革病毒包膜糖蛋白结构域III的合成肽可诱导中和抗体。
Virus Genes. 2018 Feb;54(1):25-32. doi: 10.1007/s11262-017-1508-1. Epub 2017 Sep 25.
10
Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design.抗寨卡病毒单克隆抗体:治疗方法及其对疫苗设计的启示
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01049-17. Print 2017 Oct 15.

本文引用的文献

1
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site.通过对假定的黄病毒受体结合位点进行基于结构的位点特异性诱变来减毒蜱传脑炎病毒。
J Virol. 2000 Oct;74(20):9601-9. doi: 10.1128/jvi.74.20.9601-9609.2000.
2
Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants.黄热病毒法国嗜神经疫苗株与猴脑的相互作用:猴脑膜受体逃逸变体的特征分析
J Virol. 2000 Mar;74(6):2903-6. doi: 10.1128/jvi.74.6.2903-2906.2000.
3
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.导致美国东北部脑炎疫情的西尼罗河病毒的起源。
Science. 1999 Dec 17;286(5448):2333-7. doi: 10.1126/science.286.5448.2333.
4
Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.与野生型黄热病毒的HeLa细胞减毒相关的分子和生物学变化。
Virology. 1999 Sep 1;261(2):309-18. doi: 10.1006/viro.1999.9873.
5
Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.17D - 204疫苗亚株特异性包膜蛋白表位的突变改变了黄热病病毒在小鼠体内的发病机制。
Virology. 1998 Apr 25;244(1):59-65. doi: 10.1006/viro.1998.9057.
6
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.SWISS-MODEL和Swiss-PdbViewer:一个用于比较蛋白质建模的环境。
Electrophoresis. 1997 Dec;18(15):2714-23. doi: 10.1002/elps.1150181505.
7
Phylogeny of the genus Flavivirus.黄病毒属的系统发育。
J Virol. 1998 Jan;72(1):73-83. doi: 10.1128/JVI.72.1.73-83.1998.
8
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.登革病毒的感染性取决于包膜蛋白与靶细胞硫酸乙酰肝素的结合。
Nat Med. 1997 Aug;3(8):866-71. doi: 10.1038/nm0897-866.
9
Japanese encephalitis and dengue vaccines.日本脑炎疫苗和登革热疫苗。
Biologicals. 1997 Mar;25(1):27-34. doi: 10.1006/biol.1997.0057.
10
Yellow fever vaccines.黄热病疫苗
Biologicals. 1997 Mar;25(1):17-25. doi: 10.1006/biol.1997.0056.